The forkhead family transcriptional factor (Foxp3) is an important lineage marker for regulatory T (Treg) + T cells could be recruited to expand the Treg pool upon CD25 regaining, for the effort to try to reverse a homeostatic imbalance shift to more aggressive expansion of autoreactive T cells and B cells. This hypothesis, if confirmed, would provide a new strategy for the treatment of SLE via the generation of therapeutic regulatory T cells.
INTRODUCTION

CD4
+ CD25 + Foxp3 + regulatory T (Treg) cells play a crucial role in maintaining peripheral tolerance and provide prevention from autoimmune disease [1] . It is well known that the milestone in Treg research is the discovery of the function of Foxp3. Mutation in the Foxp3 gene has been identified as the disease-causative gene in Scurfy mouse, which spontaneously develops severe autoimmunity, as well as a similar human disease called IPEX (immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome) [2, 3] . Both of these diseases arise from a lack of functional Treg cells. Foxp3 is the key molecule not only for the development and function of thymus-derived, naturally occurring Treg (nTreg) cells but also for the induced Treg (iTreg) cells which are generated in the periphery. Retroviral transduction of the Foxp3 gene converts naïve CD4 + CD25 -T cells to phenotypical and functional Treg cells [4] . + T cells present in the peripheral blood of patients with systemic lupus erythematosus (SLE) [12] [13] [14] [15] [16] . The proportion of CD4 + CD25 Foxp3 + T cells within CD4 + lymphocytes is nearly up to 8% [16] . SLE is a disorder of immune regulation characterized by the breakdown of peripheral tolerance to self-antigens and the production of various autoantibodies. Many T-cell and B-cell abnormalities have been described [17] , and these include the perturbation of Treg cell subset revealed in recent years [18] . However, the nature of CD4 + CD25 Foxp3 + T cell subset and the clinical significance of their increased quantity in patients with SLE have little known.
PHENOTYPE ANALYSIS OF CD4 + CD25 FOXP3 + T CELL
By flow-cytometric analysis, several groups reported that CD4 + CD25 Foxp3 + T cells in the peripheral blood from lupus patients expressed few level of CD127, another important phenotypic characteristic for Treg [13, 15, 16] 
CD25 Foxp3
+ T cells could be recruited to expand the Treg pool upon CD25 regaining, for the effort to try to reverse a homeostatic imbalance shift to more aggressive expansion of autoreactive T cells and B cells in SLE.
DISCUSSION
We propose this hypothesis rather than one which recognizes CD4 + CD25 Foxp3 + T cells as conventional Treg cells, based on some new findings in research of Treg in human SLE and several characteristics belonged to this autoimmune disease itself.
There is a wide spectrum in human lupus ranging from solely involvement in skin to systemic disease. Beyond initial studies about Treg in human lupus, emerging data have revealed that the proportion of CD4 + CD25 + Foxp3 + Treg cells as well as CD4 + CD25 Foxp3 + T cells in the peripheral blood of lupus patients both increase and positively correlate with disease activity [12-16, 21, 22] . As for Treg function, there is also emerging evidence supporting that a relative deficiency of Treg function, rather than an intrinsic deficiency, is involved in the development of human lupus. This abnormality may be due to the resistant effect on Treg suppression direct from effector T cells, or the blockade effect on Treg suppression indirect from antigen-presenting cells [18, 21, 22] . In fact, the phenomenon of relative insufficiency of Treg function has been reported in numerous animal models [23] . The same trend is now emerging from human studies, in particular those relating to SLE patients. This scenario just provide a rational explanation for the increased peripheral blood CD4 + CD25 + Foxp3 + Treg quantity in active lupus, which may be the positive feedback response to the resistant / blockade effect on Treg suppression. Subsequently, the following question is: Where do the increased circulating CD4 + CD25 + Foxp3 + Treg cells origin?
It is known that the CD4 + CD25 + Foxp3 + Tregs circulating in the blood consist of nTreg cells and iTreg cells. In SLE patients, nTreg apoptosis is found to be exacerbated due to more sensitive to Fas-mediated apoptosis [24] . The proliferation of limited nTreg seems unlikely sufficient for a bulge in the CD4 + CD25 + Foxp3 + Treg cell pool in the active autoimmune response. What's more, SLE is characterized by a high level of IL-6 [25] . This cytokine can interfere with the function of nTreg [26] , and can even convert nTreg cells to IL-17-producing cells [27] . Both IL-2, combined with TGF-ß, have been suggested to enable the conversion of iTreg from CD4 + CD25 Foxp3 precursors in the periphery. However, lymphocyte production of these two cytokines is shown to be decreased in SLE patients [28, 29] . Therefore, the CD4 + CD25 Foxp3 + T cell population may serve as the main replenishment for CD4 + CD25 + Foxp3 + iTreg population that could rapidly be recruited to the Treg pool upon CD25 regaining, in order to combat the more aggressive expansion of autoreactive T cells and B cells during disease flare. Fortunately, Zelenay and his colleagues addressed this question in their mice model and established that Foxp3-expressing cells encompassed in the CD45RB low CD25 subset were the cells contributing to the pool of CD25 + Treg during immune activities [30] . This finding may further support our speculation. + CD25 Foxp3 + T cells from SLE patients is necessary for their full regulatory capacity, suppressing not only proliferation but also IFN-production of effector T cells. If this is indeed the case, this would provide another strategy for the generation of therapeutic regulatory T cells for the treatment of SLE.
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